Large-scale testing (Phase 3)Study completedNCT00868296
What this trial is testing
Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)
Who this might be right for
Gastroesophageal Reflux
Wyeth is now a wholly owned subsidiary of Pfizer 58